Viva Biotech Holdings (1873.HK) HKSE

2.15

-0.01(-0.46%)

Updated at January 14 04:08PM

Currency In HKD

Valuation

Market Cap1.73B
Enterprise Value2.07B
P/E Ratio27.17
PEG Ratio2.6
Price/Sales Ratio2.21
Price/Book Ratio1.2
Enterprise/Revenue2.34
Enterprise/EBITDA10.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.12

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue1.99B
Revenue/Share0.75
Gross Profit687.4M
EBITDA428M
Net Income167.29M
Diluted EPS0.06

Balance Sheet

Total Cash904.45M
Total Cash/Share0.37
Total Debt1.16B
Total Debt/Equity0.3
Current Ratio1.76
Book Value Per Share1.6

Price History

52-Week Change168.75
52-Week High3.27
52-Week Low0.77
Moving Average 50 Days1.98
Moving Average 200 Days1.98

Statistics

Average Volume5.53M
Shares Outstanding2.11B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A